Expert Review of Pharmacoeconomics and Outcomes Research : Impact Factor & More
eISSN: 1744-8379pISSN: 1473-7167
Share this on:
Aims and Scope of Expert Review of Pharmacoeconomics and Outcomes Research
Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley (European Organisation for Research and Treatment of Cancer). Less
Key Metrics
CiteScore 
3.4
H-Index
60
Impact Factor
< 5
SJR
Q2Health Policy
SNIP
0.9
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Expert Review of Pharmacoeconomics and Outcomes Research
Expert Review of Pharmacoeconomics and Outcomes Research Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2001 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Review of Pharmacoeconomics and Outcomes Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Review of Pharmacoeconomics and Outcomes Research
Estimated cost-effectiveness of adjuvant nivolumab for resected stage IIB–IIC melanoma in the United States
- 26 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Cost and clinical analysis of community-acquired pneumonia within an antimicrobial stewardship-governed academic hospital in South Africa, and its implications
- 23 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Physicians’ preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China
- 21 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Cost-effectiveness analysis of point-of-care A1C tests in the primary care setting of Iran
- 21 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective
- 16 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Antimicrobial resistance as an economic externality: optimal control, Pigouvian taxation, and governance implications
- 16 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Estimated cost-effectiveness of adjuvant nivolumab for resected stage IIB–IIC melanoma in the United States
- 26 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Cost and clinical analysis of community-acquired pneumonia within an antimicrobial stewardship-governed academic hospital in South Africa, and its implications
- 23 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Physicians’ preferences for direct-acting antivirals in the treatment of chronic hepatitis C: evidence from a discrete choice experiment in China
- 21 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Cost-effectiveness analysis of point-of-care A1C tests in the primary care setting of Iran
- 21 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Cost of care and budget impact of novel first-line treatments in patients with locally advanced or metastatic urothelial carcinoma from the Colombian healthcare system perspective
- 16 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
Antimicrobial resistance as an economic externality: optimal control, Pigouvian taxation, and governance implications
- 16 Apr 2026
- Expert Review of Pharmacoeconomics & Outcomes Research
FAQs on Expert Review of Pharmacoeconomics and Outcomes Research
How long has Expert Review of Pharmacoeconomics and Outcomes Research been actively publishing? 
What is the publishing frequency of Expert Review of Pharmacoeconomics and Outcomes Research?
How many articles did Expert Review of Pharmacoeconomics and Outcomes Research publish last year?
What is the eISSN & pISSN for Expert Review of Pharmacoeconomics and Outcomes Research?
What is Citescore for Expert Review of Pharmacoeconomics and Outcomes Research?
What is the H Index for Expert Review of Pharmacoeconomics and Outcomes Research ?
What is SNIP score for Expert Review of Pharmacoeconomics and Outcomes Research?
What is the SJR for Expert Review of Pharmacoeconomics and Outcomes Research?
Who is the publisher of Expert Review of Pharmacoeconomics and Outcomes Research?
